Predictors of an Invasive Breast Cancer Recurrence after DCIS: A Systematic Review and Meta-analyses
- 1 May 2019
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 28 (5) , 835-845
Abstract
We performed a systematic review with meta-analyses to summarize current knowledge on prognostic factors for invasive disease after a diagnosis of ductal carcinoma in situ (DCIS). Eligible studies assessed risk of invasive recurrence in women primarily diagnosed and treated for DCIS and included at least 10 ipsilateral-invasive breast cancer events and 1 year of follow-up. Quality in Prognosis Studies tool was used for risk of bias assessment. Meta-analyses were performed to estimate the average effect size of the prognostic factors. Of 1,781 articles reviewed, 40 articles met the inclusion criteria. Highest risk of bias was attributable to insufficient handling of confounders and poorly described study groups. Six prognostic factors were statistically significant in the meta-analyses: African-American race [pooled estimate (ES), 1.43; 95% confidence interval (CI), 1.15–1.79], premenopausal status (ES, 1.59; 95% CI, 1.20–2.11), detection by palpation (ES, 1.84; 95% CI, 1.47–2.29), involved margins (ES, 1.63; 95% CI, 1.14–2.32), high histologic grade (ES, 1.36; 95% CI, 1.04–1.77), and high p16 expression (ES, 1.51; 95% CI, 1.04–2.19). Six prognostic factors associated with invasive recurrence were identified, whereas many other factors need confirmation in well-designed studies on large patient numbers. Furthermore, we identified frequently occurring biases in studies on invasive recurrence after DCIS. Avoiding these common methodological pitfalls can improve future study designs.Keywords
Funding Information
- Cancer Research UK and the Dutch Cancer Society (C38317/A24043)
This publication has 70 references indexed in Scilit:
- A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the BreastJNCI: Journal of the National Cancer Institute, 2013
- HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situBritish Journal of Cancer, 2012
- Association of RB/p16-Pathway Perturbations with DCIS RecurrenceThe American Journal of Pathology, 2011
- Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCISJNCI: Journal of the National Cancer Institute, 2011
- Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort studyBMC Cancer, 2010
- A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trialBritish Journal of Cancer, 2010
- Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ DiagnosisJNCI: Journal of the National Cancer Institute, 2010
- Abrogated Response to Cellular Stress Identifies DCIS Associated with Subsequent Tumor Events and Defines Basal-like Breast TumorsCancer Cell, 2007
- Bias: Table 1Journal of Epidemiology and Community Health, 2004
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986